Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eledon Pharmaceuticals Inc (ELDN)

Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eledon Pharmaceuticals Inc 19900 MACARTHUR BOULEVARD SUITE 550 IRVINE CA 92612 USA

https://eledon.com P: 949-238-8090

Description:

Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon Pharmaceuticals Inc., formerly known as Novus Therapeutics Inc., is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 51,115
Enterprise Value, $K 46,505
Shares Outstanding, K 24,813
Annual Sales, $ 0 K
Annual Net Income, $ -40,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,630 K
EBIT, $ -43,000 K
EBITDA, $ -42,630 K
60-Month Beta 0.87
% of Insider Shareholders 19.40%
% of Institutional Shareholders 56.77%
Float, K 19,999
% Float 80.60%
Short Volume Ratio 0.38

Growth:

1-Year Return 12.86%
3-Year Return -73.22%
5-Year Return -94.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 94.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 03/28/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -1.79
EPS Growth vs. Prev Qtr 17.14%
EPS Growth vs. Prev Year 57.35%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 10/05/20

ELDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.15%
Return-on-Assets % -43.10%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.59
Book Value/Share 3.45
Interest Coverage -2.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar